Probio 7
Natural health product licensed in Canada
- Licence holder
- ATP ATHLÉTIQUE ET THÉRAPEUTIQUE PHARMA INC. ou ATP ATHLETIC AND THERAPEUTIC PHARMA INC.
- NPN or DIN-HM
- 80082245
- Status
- Active licence
- Licence date
- 5 January 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus rhamnosus Source : Cellule entière | 3.8 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : R0011 | 3.8 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Cellule entière | 0.6 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : HA-135 | 0.6 Milliards d'UFC | Not calculated |
| Lactobacillus helveticus Source : Lactobacillus helveticus R0052 - cellule entière | 1.8 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : R-0071 | 3 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 3 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : Cellule entière | 16.8 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : HA-108 | 16.8 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : HA-119 | 18 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Cellule entière | 18 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : Cellule entière | 6 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : GG | 6 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Cellulose microcristalline, Vitamine C, Sels de potassium d'acides gras (en C12 à C20)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support intestinal/gastrointestinal health. Could promote favorable gut flora. Helps reduce the incidence of cold-like symptoms in stressed adults. Probiotic to benefit health and/or confer a health benefit. Reduces the duration of acute infectious diarrhea. An adjunct to physician-supervised therapy in patients with Helicobacter pylori infections. For the maintenance of a balanced vaginal flora by pregnant women who have undergone a caesarean section and undergoing post-operative antibiotic therapy. Helps maintain a healthy microflora in adults and pregnant women who are undergoing antibiotic therapy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80082245
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.